Cannabis Stock Gainers And Losers From November 8, 2019

Gainers

• Aurora Cannabis ACB shares gained 6.31%, closing at $3.81.
• Aphria APHA shares gained 5.19%, closing at $5.07.
• Canopy Growth CGC shares increased by 12.53% to close at $21.47.
• Cresco Labs CRLBF shares increased by 0.07% to close at $6.50.
• Cronos Group CRON shares gained 7.44%, closing at $8.52.
• CannTrust Holdings CTST shares gained 1.46%, closing at $1.04.
• Fire & Flower Holdings FFLWF shares increased by 3.08% to close at $0.75.
• GW Pharmaceuticals GWPH shares gained 0.34%, closing at $109.41.
• HEXO HEXO shares gained 6.25%, closing at $2.35.
• Harvest Health HRVSF shares gained 12.66%, closing at $2.82.
• Innovative Industrial IIPR shares rose 6.74%, to close at $85.21.
• Akerna KERN shares rose 0.47%, to close at $4.24.
• KushCo Holdings KSHB shares rose 11.59%, to close at $1.83, after raising guidance for fiscal 2020.
• MediPharm Labs MEDIF shares gained 2.83%, closing at $4.02.
• MedMen Enterprises MMNFF shares gained 1.85%, closing at $1.10.
• OrganiGram Holdings OGI shares increased by 3.98% to close at $3.66.
• Planet 13 Holdings PLNHF shares gained 6.06%, closing at $1.40.
• Pyxus International PYX shares increased by 12.15% to close at $10.34, amid posting a smaller than expected Q2 loss.
• Sundial Growers SNDL shares gained 8.26%, closing at $3.80.
• Supreme Cannabis Co SPRWF shares increased by 3.72% to close at $0.65.
• Tilray TLRY shares rose 5.31%, to close at $23.42.
• Valens Groworks VGWCF shares rose 7.59%, to close at $2.55.

Losers

• Columbia Care CCHWF shares dropped by 5.4%, to close at $2.98, after announcing its $140 million acquisition of The Green Solution.
• Greenlane Holdings GNLN shares tumbled by 2.56%, eventually closing at $3.81, after reporting a $9 million quarterly loss and only 3% YoY quarterly sales growth.
• Therapix Biosciences TRPX shares dropped by 28.16%, to close at $1.76.
• cbdMD YCBD shares tumbled by 0.5%, eventually closing at $3.99.
• Zynerba Pharmaceuticals ZYNE shares tumbled by 0.31%, eventually closing at $6.43.

Related Links:

Quicksilver Scientific CEO: Public Understands CBD's Benefits, But Regulatory Roadblocks Need To Be Eliminated

Cannabis 2.0: The Companies Entering Canada's New Edible, Concentrate, Topical Market